trending Market Intelligence /marketintelligence/en/news-insights/trending/LrTtTpGr2L1EeBOHz_khkw2 content esgSubNav
In This List

CohBar appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


CohBar appoints director

CohBar Inc. appointed John Amatruda to the board.

Amatruda is a co-founder and scientific adviser to the company. He is also currently on the board of CureDM, Prosciento, and Fractyl.

CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics for age-related diseases.